US Stock MarketDetailed Quotes

Silence Therapeutics (SLN)

Watchlist
  • 7.040
  • +0.060+0.86%
Trading May 14 15:56 ET
332.53MMarket Cap-4.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Silence Therapeutics (SLN) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
RNA therapeutics422K100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United Kingdom (U.K.)559K100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +15.28%
Sample Name
Sample Code
 +14.31%
4
United States Oil Fund LP
USO
+13.39%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.00%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.52%
Sample Name
Sample Code
 +9.52%
Sample Name
Sample Code
 +8.79%
4
Hesai
HSAI
+8.46%
5
NIO Inc
NIO
+6.73%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -